Sterimed’s UK subsidiary, Westfield Medical, has acquired Granton Medical, a prominent UK provider of medical packaging solutions.
- Granton Medical is a pioneer in sterile packs for single-use surgical blades and the largest UK manufacturer of self-seal pouches.
- The acquisition enhances Sterimed’s product portfolio, particularly in contract packing and services for medical device companies.
- RWK Goodman and Bishop Fleming provided legal and financial advisory services to Sterimed during the acquisition.
- Key figures express optimism, highlighting growth opportunities and strategic benefits for both companies and their employees.
Sterimed, through its UK subsidiary Westfield Medical, has recently finalised the acquisition of Granton Medical. This acquisition marks a significant addition to Sterimed’s portfolio in the medical packaging sector, as Granton Medical is renowned for its innovation and leadership in providing sterile packs for single-use surgical blades since the 1960s.
Granton Medical currently holds the title as the UK’s largest manufacturer of self-seal pouches that are crucial for sterilization centres and hospitals. It has also developed the Cleanline® brand, offering a robust suite of services in medical device cleaning, assembly, and packaging within an ISO Class 7 cleanroom environment. Additionally, Granton supplies printed roll stock of sterilizable packaging materials to a diverse array of medical device manufacturers.
The acquisition is poised to significantly advance Sterimed’s presence in the UK market, especially in contract packing and associated services to medical device companies. This strategic move is aligned with Sterimed’s broader ambition to broaden its product and service offerings within the industry. Notably, the deal underscores Sterimed’s commitment to expanding its global reach and strengthening its product range.
Legal and financial guidance for Sterimed was provided by RWK Goodman and Bishop Fleming, with key personnel including James Worrall, Freya Still, Tim Gofton, Dan Pinheiro, Joe Coghlan, and Charles Davey playing pivotal roles in facilitating the acquisition. These advisors ensured a smooth transition and integration process, highlighting the collaborative effort involved.
Expressions of enthusiasm and forward-looking optimism were shared by various stakeholders, including Thibaut Hyvernat, President and CEO of Sterimed, who emphasised the complementary nature of the acquisition. Hyvernat articulated the potential for enhanced global positioning and growth, leveraging the entrepreneurial spirit of both companies. Meanwhile, Peter Kirkby, former Chairman of Granton Medical, reflected optimism about the new chapter for Granton under Sterimed’s umbrella.
The acquisition of Granton Medical by Sterimed signifies a promising development for both entities, underpinning future growth and market expansion.
